Equinor ASA (EQNR) Stock Price Today
Aura AI Summary
Key Stats
- $92.55BMarket Cap
- -Volume
- EnergySector
- $42.4052W High
- $22.4152W Low
- -Typical Hold Time
- $101.25BEnterprise Value
- 3.85%Div Yield
- -Trading Activity
Track Equinor ASA (EQNR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Equinor ASA has traded between a low of $22.41 and a high of $42.4, highlighting its annual price range. Buy and sell Equinor ASA shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Most Recent News
Medline stock drops over 19% after FDA cites major manufacturing violations and lowers earnings forecast.
Medline Inc. faced significant FDA violations related to manufacturing quality, including failure to investigate contamination and cleaning issues, leading to a stock drop of over 7% initially. The stock further fell by more than 12% following disapp...

Airbnb stock hits new high on strong Q2 results and AI-driven growth strategy
Airbnb's stock surged to a 52-week high of $176.40 following strong financial results, including a 17% revenue increase and 16% growth in Gross Booking Value. Analysts from Evercore ISI and Wedbush raised their price targets to $190 and $200 respecti...

Aberdeen Healthcare Investors fund offers 56% NAV return and 12% distribution, trading at 6.4% discount.
Aberdeen Healthcare Investors (HQH) is a biotech-focused closed-end fund trading at a 6.4% discount to its net asset value (NAV). Over the past year, the fund delivered a strong 56% NAV return, benefiting from favorable FDA regulatory changes and mer...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.